Pelthos Therapeutics Inc. PTHS Business Segments
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|
| Comprehensive loss by Business | |||||
| Commercial operations | -$37.26M-33.3% | -$27.95M-50.0% | -$18.63M-100% | -$9.32M— | |
| Research and Development operations | -$6.06M+7.3% | -$6.53M+6.8% | -$7.01M+6.3% | -$7.48M+6.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Pelthos Therapeutics Inc. break its business down?
- Pelthos Therapeutics Inc. (PTHS) reports total revenue by business across 2 parts — Commercial operations and Research and Development operations. Each is extracted from the segment footnotes and tracked over time.
- Where does Pelthos Therapeutics Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Pelthos Therapeutics Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
